Omeros (OMER) Revenue (QoQ) (2010 - 2021)
Omeros (OMER) Revenue (QoQ) (2010 - 2021) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Omeros |
737.87 Mn |
602.55 Mn |
9.31 Mn |
| Date | Value |
|---|
| Sep 30, 2021 |
4.10% |
| Jun 30, 2021 |
36.85% |
| Mar 31, 2021 |
98.09% |
| Dec 31, 2020 |
-59.29% |
| Sep 30, 2020 |
93.01% |
| Jun 30, 2020 |
-42.52% |
| Mar 31, 2020 |
-29.57% |
| Dec 31, 2019 |
11.93% |
| Sep 30, 2019 |
11.60% |
| Jun 30, 2019 |
22.84% |
| Mar 31, 2019 |
-1.08% |
| Dec 31, 2018 |
377.80% |
| Sep 30, 2018 |
178.43% |
| Jun 30, 2018 |
4.22% |
| Mar 31, 2018 |
-88.46% |
| Dec 31, 2017 |
-36.47% |
| Sep 30, 2017 |
26.28% |
| Jun 30, 2017 |
39.93% |
| Mar 31, 2017 |
-5.02% |
| Dec 31, 2016 |
14.31% |
